Pfizer plots euro-sterling bond sale

Pfizer plans to sell a benchmark-sized four-part bond denominated in euros and sterling, one of the banks managing the sale said. Proceeds from the sale of the bonds, which will consist of four-year, seven-year and 12-year euro-denominated tranches and a 29-year sterling-denominated bond, will help fund its $68 billion takeover of Wyeth. Report

Suggested Articles

It’s final: England won’t be covering AZ’s quick-selling Tagrisso in previously untreated non-small cell lung cancer patients with EGFR mutatations.

Top J&J meds have managed to hang onto market share in the face of new generics and biosims, but the drugmaker expects the pain to continue in 2020.

Lonza’s search for a new CEO is expected to be wrapped up this year as the CDMO homes in on a list of veterans from outside the company.